[A preliminary study on role of acid sphingomyelinase in receptor clustering induced by 50-Hz magnetic fields].
Abstract
OBJECTIVE: To investigate the relationship among a 50-Hz MF-induced epidermal growth factor receptor (EGFR) clustering, acid sphingomyelinase (A-SMase) and ceramide (CER), and to explore the possible mechanism of receptor clustering. METHODS: Human amnion (FL) cells were exposed to a 50-Hz sinusoidal magnetic field at 0.4 mT for 15 min with or without imipramine, a specific inhibitor of A-SMase and ceramide pretreatment. EGF treatment served as the positive control and DMSO treatment served as the solvent control. The EGFR was labeled with polyclonal anti-EGFR antibody and the clustering of EGFR was analyzed using immunofluorescence and confocal microscopy. The percentage of cells with EGFR clustering was counted and compared. RESULTS: Both EGF treatment and 50-Hz MF exposure could induce EGFR clustering. However, the effect could be eliminated by imipramine pretreatment for 4 hours. When FL cells were incubated with ceramide following the imipramine pretreatment for 30 min, EGFR clustering induced by 50-Hz MF exposure could be recovered. CONCLUSION: EGFR clustering induced by 50-Hz MF depends on A-SMase activity, and ceramide, as the hydrolyzate from A-SMase might participate in the process of EGFR clustering.
AI evidence extraction
Main findings
In human amnion (FL) cells, both EGF treatment and 50-Hz magnetic field exposure (0.4 mT, 15 min) induced EGFR clustering. Imipramine pretreatment (A-SMase inhibitor) eliminated the magnetic-field-induced clustering, and subsequent ceramide incubation after imipramine restored clustering induced by magnetic field exposure.
Outcomes measured
- EGFR clustering (immunofluorescence/confocal microscopy; % cells with clustering)
- Role of acid sphingomyelinase (A-SMase) activity in EGFR clustering
- Effect of ceramide on EGFR clustering after A-SMase inhibition
Limitations
- In vitro cell study; findings may not generalize to humans
- Sample size not reported in abstract
- Short exposure duration (15 min)
- Outcome is a cellular signaling/structural endpoint (EGFR clustering), not a clinical health outcome
Suggested hubs
-
occupational-exposure
(0.35) Published in an industrial hygiene/occupational diseases journal and involves 50-Hz magnetic field exposure relevant to workplace ELF MF contexts.
View raw extracted JSON
{
"study_type": "in_vitro",
"exposure": {
"band": "ELF",
"source": null,
"frequency_mhz": 0.05000000000000000277555756156289135105907917022705078125,
"sar_wkg": null,
"duration": "15 min"
},
"population": null,
"sample_size": null,
"outcomes": [
"EGFR clustering (immunofluorescence/confocal microscopy; % cells with clustering)",
"Role of acid sphingomyelinase (A-SMase) activity in EGFR clustering",
"Effect of ceramide on EGFR clustering after A-SMase inhibition"
],
"main_findings": "In human amnion (FL) cells, both EGF treatment and 50-Hz magnetic field exposure (0.4 mT, 15 min) induced EGFR clustering. Imipramine pretreatment (A-SMase inhibitor) eliminated the magnetic-field-induced clustering, and subsequent ceramide incubation after imipramine restored clustering induced by magnetic field exposure.",
"effect_direction": "harm",
"limitations": [
"In vitro cell study; findings may not generalize to humans",
"Sample size not reported in abstract",
"Short exposure duration (15 min)",
"Outcome is a cellular signaling/structural endpoint (EGFR clustering), not a clinical health outcome"
],
"evidence_strength": "low",
"confidence": 0.7399999999999999911182158029987476766109466552734375,
"peer_reviewed_likely": "yes",
"keywords": [
"50-Hz magnetic field",
"ELF MF",
"0.4 mT",
"EGFR clustering",
"acid sphingomyelinase",
"ceramide",
"imipramine",
"FL cells",
"confocal microscopy"
],
"suggested_hubs": [
{
"slug": "occupational-exposure",
"weight": 0.34999999999999997779553950749686919152736663818359375,
"reason": "Published in an industrial hygiene/occupational diseases journal and involves 50-Hz magnetic field exposure relevant to workplace ELF MF contexts."
}
]
}
AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.